You are here

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Albacete, , 2006 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Kidney Failure, Kidney Diseases
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Renal transplantation

- Biopsy-confirmed chronic rejection

- Treatment with mofetil mycophenolate among cyclosporine or tacrolimus

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Transplant of any organ other than the kidney

- Current important infection

- Acute rejection within 12 weeks prior to inclusion

NCT00282217
Pfizer
Completed
Study Evaluating Sirolimus in the Treatment of Kidney Transplant

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now